Inhibition of this pathway in CNS endothelial cells can result in increased expression of Cav‐1 and vascular cell adhesion molecule‐1, thereby enhancing endothelial cell transcytosis and exacerbating the symptoms of MS [113]. This evidence concerns the gene CAV1 and myeloid sarcoma.